Policy & Medicine - Legal, Regulatory, and Compliance Issues

On February 9, 2023, the Centers for Medicare & Medicaid Services (CMS) published two “initial” guidance documents (Part B and…

AMGA recently sent a letter to the Federal Trade Commission (FTC) regarding the agency’s proposed Non-Compete Clause Rule,…

Laurence Doud, III, the former CEO of the Rochester Drug Co-Operative, Inc. (RDC) was recently sentenced to 27 months in prison…

The United States Department of Justice (DOJ) recently announced an $825,000 settlement with a neurosurgeon and his fiancée over…

The Inflation Reduction Act had far-reaching implications for the health care industry, including the timeline Congress set for…

California Attorney General Rob Bonta recently announced a settlement with The Pill Club, an online women’s pharmacy, over…

The United States Department of Justice (DOJ) recently withdrew three policy statements regarding health care antitrust…

Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…

We wrote in 2020 about the hefty fines levied against Novartis and Roche for allegedly engaging in anti-competitive practices with…

The Government Accountability Office (GAO) recently released a report, saying the United States Food and Drug Administration (FDA)…